SVB Leerink analyst Thomas Smith maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Market Perform and lowers the price target from $27 to $21.
Asia And Europe Markets Mostly In Green, Crude Oil And Gold Gain – Global Markets Today While Us Was Sleeping
On Thursday, December 14th, U.S. stock markets ended positively as Treasury yields reached their lowest in months, driven by a shift in investor focus away from growth stocks due to the Fed's dovish position.
